Gynecology team joins Tampa General Hospital Cancer Institute
November 16, 2021
Tampa General Hospital announced that it has appointed Dr Thomas J. Rutherford, Dr Matthew L. Anderson and Dr Diana P. English, a team of highly experienced gynecologist oncologists and national leaders in surgical management and Medical Center for Precancerous Diseases and Malignant Diseases of the Female Reproductive System, at its Cancer Institute.
The three doctors will be part of an excellent gynecologic oncology program that connects patients with advanced treatment options and research trials, while providing compassionate care that takes into account the needs of the whole person. They will continue to see patients in their current practice locations. All three are also on faculty at USF Health Morsani College of Medicine.
“I am delighted that Drs. Rutherford, Anderson and English are joining the TGH Cancer Institute to not only provide the best comprehensive and compassionate care to our patients with gynecological malignancies, but also to strengthen our leadership team as we define and put implementing an innovative continuum of prevention, diagnosis, treatment, high-risk genetic screening and survival of our cancer patients. With their prestigious university degrees and passion for excellence and for translational and clinical research, our gynecological oncology program will be at the forefront of developing new therapies and connecting patients with gynecological tumors with advanced treatment options in a compassionate environment, ”said Tampa General’s Cancer Institute Director Dr. Eduardo M. Sotomayor.
Dr Thomas J. Rutherford
Advocating for comprehensive cancer care
Rutherford’s exemplary academic career to date began in Yale University School of Medicine, where he was professor and director of the division of gynecologic oncology. He was also the Director of the Gynecologic Oncology Fellowship Program, where he mentored several outstanding interns who went on to become successful academics, including Anderson and English. Rutherford was later appointed director of cancer services at the Western Connecticut Health Network. He is currently Professor and Director of the Division of Obstetrics and Gynecology at USF Health Morsani College of Medicine and Associate Director of Education, Training and Quality Care at TGH Cancer Institute.
In addition to being a nationally recognized leader, gifted surgical oncologist and mentor, Rutherford is an accomplished physician-researcher who has authored over 100 scientific journal articles on prevention, early detection and the treatment of gynecological cancers, in particular ovarian cancer.
“Cancer patient care encompasses a continuum from prevention and high-risk genetic screening to individualized treatment, survival and beyond,” said Rutherford.
Dr Matthew L. Anderson
Nationally recognized translational cancer researcher
Anderson is a nationally recognized translational cancer researcher who uses cutting-edge surgical approaches, including minimally invasive and robotic surgery, to provide his patients with the best clinical outcomes in a compassionate, patient-centered environment. . Translational medicine is the process of using the results of laboratory research to develop new diagnostic tools and treatments, and similarly using the research results of clinical trials to develop new research ideas.
As a physician-scientist, Anderson leverages his expertise in genetics / genomics and advanced process to collect pre-malignant, malignant and surrounding normal (bioreferential) tissues to identify new targets and help its patients to better understand their disease. and personalize their treatment. Her expertise is particularly useful for patients seeking options to manage an inherited predisposition to ovarian and / or uterine cancer.
Anderson is a Full Professor in the Department of Obstetrics and Gynecology at USF Health Morsani College of Medicine and has been appointed Associate Director for Shared Resources, TGH Cancer Institute, which includes a cancer research sample bio-repository, between other carrots under development, to support fundamental / translational and clinical researchers at the Cancer Institute. His highly translational lab at USF Health Morsani College of Medicine has received several local, state, and federal grants.
Anderson is also the author of over 100 manuscripts in international refereed journals highlighting his commitment to academic excellence. He trained in Obstetrics and Gynecology at Yale-New Haven Hospital, where he received his medical degree and his Doctorate of Philosophy in Cellular and Molecular Biology. Anderson completed his scholarship in Gynecologic Oncology at the MD Anderson Cancer Center at the University of Texas. He is a fellow of the American College of Obstetrics and Gynecology.
“My goal is to integrate cutting-edge surgical approaches such as minimally invasive and robotic surgery with molecularly targeted agents to achieve the best possible outcomes for our patients, while applying my research experience to help patients understand and to personalize the therapeutic approach, ”Anderson said. “It creates opportunities for patients beyond traditional chemotherapy.”
Dr Diana P. English
Highly Qualified and Compassionate Oncology Surgeon
English received two scholarships during his medical training – a scholarship in gynecologic oncology at the Yale School of Medicine and a scholarship in palliative medicine and palliative care at Stanford University and the clinics in Palo Alto, California. She specializes in the diagnosis and surgical / medical treatment of all gynecologic cancers and is currently Director and Associate Professor of Palliative Care in Oncology at USF Health Morsani College of Medicine. At the TGH Cancer Institute, English will be the co-leader of the oncology support program. English uses minimally invasive approaches, in particular robotic and laparoscopic surgery, for the surgical management of patients with cancers of the reproductive system.
She is also the Director of the USF Health Gynecologic Oncology Fellowship, where she is involved in the day-to-day management of the Next Generation Gynecologist-Oncologist training program.
Additionally, she is a dedicated researcher who has contributed to several original manuscripts related to targeted therapeutic approaches for serous uterine cancer and ovarian cancer, health disparity research, and supportive cancer care. Cancer. English is also actively involved in international service, particularly medical missions in developing countries, and has received several accolades for her passion to help patients in need of her expertise. She is a fellow of the American College of Obstetrics and Gynecology. “Treating cancer patients means taking all aspects into account. When I treat a patient, I focus on the medical aspects of their treatment, as well as all the patient’s needs so that they feel supported throughout their cancer journey, ”said English.
The three doctors provide highly specialized care and use new approaches, including heated intraperitoneal chemotherapy to treat patients with cancers of the reproductive system.
Building on the achievements of the Tampa General Hospital Oncology Program – ranked among the top 10 percent of best cancer care in the United States according to US News & World Report’s 2021-2022 rankings – the new Cancer Institute at Tampa General Hospital provides comprehensive care through therapies, highly complex surgical procedures, and advanced diagnostic imaging and radiation therapy tools.
“This team of highly experienced and nationally recognized specialists brings a wealth of knowledge and insight into scientific publications in the surgical and medical management of pre-malignant and malignant diseases of the female reproductive system and in providing second opinions, Gynecologic Complex Consultations and Treatments They join a world-class team that will help us achieve our vision of providing the safest and most innovative treatment and care for our cancer patients and their families, ”said the Dr Abraham Schwarzberg, Senior Vice President of Oncology and Network Development at Tampa General Hospital. “The addition of Rutherford, Anderson and English to the Cancer Institute group underscores Tampa General’s priority to provide innovative care for foreground to cancer patients in a leading academic medical center. ”
Through the Cancer Institute, Tampa General oncologists will offer a highly coordinated range of multidisciplinary specialties such as hematologic malignancies, stem and cell therapy, neuro-oncology, thoracic, breast, colorectal, urologic oncology and gynecological. Advanced subspecialties will also be offered, particularly in hepatic and hepatobiliary oncology, otolaryngology (ear, nose and throat) and genitourinary (reproductive system and genitourinary system). Tampa General will continue to take a multidisciplinary approach with a strong emphasis on compassionate and personalized care that is centered on the whole patient.
“One of the central priorities of our Cancer Institute is the training of the next generation of cancer researchers, particularly physician-researchers, who are in high demand in our region and nationally. these efforts. Being a physician-researcher myself, I look forward to working with this exceptional team of accomplished mentors and educators, ”said Sotomayor.
For more information about the Tampa General Cancer Institute, visit www.tgh.org/cancer.
This press release was produced by TGH. The opinions expressed here are those of the author.